Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zahi Touma

Showing results (41-50 of 215) with videos related to

Pageof 22
Sort By:
Rheumatology (Oxford, England)|January 12, 2022
What are the domains and outcome measures used in the existing neuropsychiatric systemic lupus erythematosus literature?Kathleen S Bingham, Vibeke Strand, Lee S Simon, et al.
Best Practice & Research. Clinical Rheumatology|November 22, 2023
Systemic lupus erythematosus and damage: What has changed over the past 20 years?Carolina Muñoz-Grajales, Esin Beste Yilmaz, Elisabet Svenungsson, et al.
The Journal of Rheumatology|October 1, 2025
Improving Mental Health Care for People With Systemic Lupus Erythematosus: Time to Take ActionTamar B Rubinstein, Zahi Touma, Irene Blanco, et al.
Arthritis Care & Research|October 22, 2020
Measures of Cognition in Rheumatic DiseasesKimberley Yuen, Kathleen Bingham, Oshrat E Tayer-Shifman, et al.
Rheumatology (Oxford, England)|November 29, 2011
Ability of non-fasting and fasting triglycerides to predict coronary artery disease in lupus patientsZahi Touma, Dafna D Gladman, Dominique Ibañez, et al.
Lupus Science & Medicine|June 28, 2020
Measurement properties of selected patient-reported outcome measures for use in randomised controlled trials in patients with systemic lupus erythematosus: a systematic reviewVibeke Strand, Lee S Simon, Alexa Simon Meara, et al.
The Journal of Rheumatology|July 5, 2011
Is there an advantage over SF-36 with a quality of life measure that is specific to systemic lupus erythematosus?Zahi Touma, Dafna D Gladman, Dominique Ibañez, et al.
ACR Open Rheumatology|December 14, 2020
Exploring the Mental Health Needs of Persons With Autoimmune Diseases During the Coronavirus Disease 2019 Pandemic: A Proposed Framework for Future Research and Clinical CareKathleen S Bingham, Nathalie Rozenbojm, Mariah Chong-East, et al.
Rheumatology (Oxford, England)|July 14, 2021
What are the domains and outcome measures used in the existing neuropsychiatric systemic lupus erythematosus literature?Kathleen S Bingham, Vibeke Strand, Lee S Simon, et al.
Rheumatology International|June 15, 2007
The use of TNF-alpha blockers in Cogan's syndromeZahi Touma, Rita Nawwar, Usamah Hadi, et al.
Pageof 22

Showing results (41-50 of 215) with videos related to

Sort By:
Pageof 22
Rheumatology (Oxford, England)|January 12, 2022
What are the domains and outcome measures used in the existing neuropsychiatric systemic lupus erythematosus literature?Kathleen S Bingham, Vibeke Strand, Lee S Simon, et al.
Best Practice & Research. Clinical Rheumatology|November 22, 2023
Systemic lupus erythematosus and damage: What has changed over the past 20 years?Carolina Muñoz-Grajales, Esin Beste Yilmaz, Elisabet Svenungsson, et al.
The Journal of Rheumatology|October 1, 2025
Improving Mental Health Care for People With Systemic Lupus Erythematosus: Time to Take ActionTamar B Rubinstein, Zahi Touma, Irene Blanco, et al.
Arthritis Care & Research|October 22, 2020
Measures of Cognition in Rheumatic DiseasesKimberley Yuen, Kathleen Bingham, Oshrat E Tayer-Shifman, et al.
Rheumatology (Oxford, England)|November 29, 2011
Ability of non-fasting and fasting triglycerides to predict coronary artery disease in lupus patientsZahi Touma, Dafna D Gladman, Dominique Ibañez, et al.
Lupus Science & Medicine|June 28, 2020
Measurement properties of selected patient-reported outcome measures for use in randomised controlled trials in patients with systemic lupus erythematosus: a systematic reviewVibeke Strand, Lee S Simon, Alexa Simon Meara, et al.
The Journal of Rheumatology|July 5, 2011
Is there an advantage over SF-36 with a quality of life measure that is specific to systemic lupus erythematosus?Zahi Touma, Dafna D Gladman, Dominique Ibañez, et al.
ACR Open Rheumatology|December 14, 2020
Exploring the Mental Health Needs of Persons With Autoimmune Diseases During the Coronavirus Disease 2019 Pandemic: A Proposed Framework for Future Research and Clinical CareKathleen S Bingham, Nathalie Rozenbojm, Mariah Chong-East, et al.
Rheumatology (Oxford, England)|July 14, 2021
What are the domains and outcome measures used in the existing neuropsychiatric systemic lupus erythematosus literature?Kathleen S Bingham, Vibeke Strand, Lee S Simon, et al.
Rheumatology International|June 15, 2007
The use of TNF-alpha blockers in Cogan's syndromeZahi Touma, Rita Nawwar, Usamah Hadi, et al.
Pageof 22